PUBLIC LAW 107-280—NOV. 6, 2002 116 STAT. 1991 agencies of the National Institutes of Health and by the Food and Drug Administration to the extent that such institutes, centers and agencies have responsibilities that are related to rare diseases. "(c) USES FOR FEDERAL PAYMENTS UNDER COOPERATIVE AGREE- MENTS OR GRANTS.— Federal payments made under a cooperative agreement or grant under subsection (a) may be used for— "(1) staffing, administrative, and other basic operating costs, including such patient care costs as are required for research; "(2) clinical training, including training for allied health professionals, continuing education for health professionals and allied health professions personnel, and information programs for the public with respect to rare diseases; and "(3) clinical research and demonstration programs. "(d) PERIOD OF SUPPORT; ADDITIONAL PERIODS. —Support of a center under subsection (a) may be for a period of not to exceed 5 years. Such period may be extended by the Director for additional periods of not more than 5 years if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period should be extended. " (e) AUTHORIZATION OF APPROPRL\TIONS. —For the purpose of carrying out this section, there are authorized to be appropriated such sums as already have been appropriated for fiscal year 2002, and $20,000,000 for each of the fiscal years 2003 through 2006.". Approved November 6, 2002. LEGISLATIVE HISTORY—H.R. 4013 (S. 1379): HOUSE REPORTS: No. 107-543 (Comm. on Energy and Commerce). SENATE REPORTS: No. 107-129 accompanying S. 1379 (Comm. on Health, Education, Labor, and Pensions). CONGRESSIONAL RECORD, Vol. 148 (2002): Oct. 1, considered and passed House. Oct. 17, considered and passed Senate.
�
